Regulators in the EU to increase the efficiency of paediatric regulatory processes

  • Home
  • Newsroom
  • Regulators in the EU to increase the efficiency of paediatric regulatory processes
Regulators in the EU to increase the efficiency of paediatric regulatory processes - Axcellant

Regulators in the EU to increase the efficiency of paediatric regulatory processes

  1. kwi 15, 2023

Regulators in the European Union (EU) have taken several initiatives in the past four years to increase the efficiency of paediatric regulatory processes and boost the development of medicines for children.

These achievements are highlighted in the PDF icon closing report of the EMA and European Commission (EC) action plan on paediatrics.

The Paediatric Regulation came into force in the EU in 2007 to encourage manufacturers to research and develop medicines for children’s specific therapeutic needs by using a system of rewards and obliging developers to specifically plan the development of their medicine for children (e.g. by integrating it into the development for adults) and submit a corresponding PIP.

A PIP is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for paediatric patients. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral or waiver.

https://www.ema.europa.eu/en/news/actions-support-development-medicines-children

Read more

Key Considerations for Initiating a Clinical Trial: A Comprehensive Guide

Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…

Completion of a significant clinical study

Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study. This study was…

Unveiling Real-World Evidence in Clinical Trials

In the ever-evolving realm of pharmaceuticals and healthcare, a remarkable transformation is afoot - one that's reshaping the way we…